Open the mobile version, with barcode scanning
Class II Ongoing

Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation,…

Why: CGMP Deviations

Company
Baxter Healthcare Corporation
Deerfield, IL, United States
Reported
Sep 9, 2026
Recall started
Aug 6, 2026
Where sold
US Nationwide; Puerto Rico; and Chile.
Amount
N/A
Full product description
Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24.
Lots / codes affected
Lot # NC188692, Exp Date: 11/22/2027.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.